SUSAN BLANEY to Proteasome Inhibitors
This is a "connection" page, showing publications SUSAN BLANEY has written about Proteasome Inhibitors.
Connection Strength
0.237
-
Phase I study of the proteasome inhibitor bortezomib in pediatric patients with refractory solid tumors: a Children's Oncology Group study (ADVL0015). J Clin Oncol. 2004 Dec 01; 22(23):4804-9.
Score: 0.237